文献
J-GLOBAL ID:201802226780613360
整理番号:18A2160359
乳癌患者において同定されたBRCA1およびBRCA25′非コード領域変異体はプロモーター活性および蛋白質結合を変化させる【JST・京大機械翻訳】
BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding
著者 (46件):
Burke Leslie J.
(School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia)
,
Sevcik Jan
(School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia)
,
Sevcik Jan
(Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic)
,
Gambino Gaetana
(School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia)
,
Gambino Gaetana
(Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy)
,
Tudini Emma
(School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia)
,
Tudini Emma
(Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia)
,
Mucaki Eliseos J.
(University of Western Ontario, Department of Biochemistry, Schulich School of Medicine and Dentistry, London, Ontario, Canada)
,
Shirley Ben C.
(CytoGnomix Inc., London, Ontario, Canada)
,
Whiley Phillip
(School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia)
,
Whiley Phillip
(Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia)
,
Parsons Michael T.
(Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia)
,
De Leeneer Kim
(Center for Medical Genetics, Ghent University Hospital, and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium)
,
Gutierrez-Enriquez Sara
(Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)
,
Santamarina Marta
(Fundacion Publica Galega de Medicina Xenomica-SERGAS, Grupo de Medicina Xenomica-USC, CIBERER, IDIS, Santiago de Compostela, Spain)
,
Caputo Sandrine M.
(Service de Genetique, Department de Biologie des Tumeurs, Institut Curie, Paris, France)
,
Santana dos Santos Elizabeth
(Service de Genetique, Department de Biologie des Tumeurs, Institut Curie, Paris, France)
,
Santana dos Santos Elizabeth
(Department of oncology, Center for Translational Oncology, Cancer Institute of the State of Sao Paulo - ICESP, Sao Paulo, Brazil)
,
Santana dos Santos Elizabeth
(A.C.Camargo Cancer Center, Sao Paulo, Brazil)
,
Soukupova Jana
(Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic)
,
Janatova Marketa
(Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic)
,
Zemankova Petra
(Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic)
,
Lhotova Klara
(Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic)
,
Stolarova Lenka
(Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic)
,
Borecka Mariana
(Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic)
,
Moles-Fernandez Alejandro
(Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)
,
Manoukian Siranoush
(Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy)
,
Bonanni Bernardo
(Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy)
,
ENIGMA Consortium
(School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia)
,
Edwards Stacey L.
(Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia)
,
Blok Marinus J.
(Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands)
,
van Overeem Hansen Thomas
(Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark)
,
Rossing Maria
(Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark)
,
Diez Orland
(Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)
,
Diez Orland
(Area of Clinical and Molecular Genetics, University Hospital Vall d’Hebron (UHVH), Barcelona, Spain)
,
Vega Ana
(Fundacion Publica Galega de Medicina Xenomica-SERGAS, Grupo de Medicina Xenomica-USC, CIBERER, IDIS, Santiago de Compostela, Spain)
,
Claes Kathleen B.M.
(Center for Medical Genetics, Ghent University Hospital, and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium)
,
Goldgar David E.
(Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah)
,
Rouleau Etienne
(Gustave Roussy, Villejuif, France)
,
Radice Paolo
(Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy)
,
Peterlongo Paolo
(IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy)
,
Rogan Peter K.
(University of Western Ontario, Department of Biochemistry, Schulich School of Medicine and Dentistry, London, Ontario, Canada)
,
Rogan Peter K.
(CytoGnomix Inc., London, Ontario, Canada)
,
Caligo Maria
(Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy)
,
Spurdle Amanda B.
(Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia)
,
Brown Melissa A.
(School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia)
資料名:
Human Mutation
(Human Mutation)
巻:
39
号:
12
ページ:
2025-2039
発行年:
2018年
JST資料番号:
W2601A
ISSN:
1059-7794
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)